- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nuformix PLC (NFXN)
Nuformix PLC stock price live, this page displays LON NFXN stock exchange data. View the NFXN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Nuformix PLC real time stock price chart below.
What Is the Nuformix PLC Stock Price Today?
The Nuformix PLC stock price today is 0.2300.
What Is the Stock Symbol for Nuformix PLC?
The stock ticker symbol for Nuformix PLC is NFXN.
Is NFXN the Same as $NFXN?
$NFXN is a common way to refer to the Nuformix PLC ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Nuformix PLC Trade On?
Nuformix PLC is listed and trades on the London stock exchange.
Is Nuformix PLC a Good Stock to Buy?
Determining whether Nuformix PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Nuformix PLC share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NFXN quote. (ISIN: GB00BYW79Y38)
What Is the Nuformix PLC Stock Price Today?
The Nuformix PLC stock price today is 0.2300.
What Is the Stock Symbol for Nuformix PLC?
The stock ticker symbol for Nuformix PLC is NFXN.
Is NFXN the Same as $NFXN?
$NFXN is a common way to refer to the Nuformix PLC ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Nuformix PLC Trade On?
Nuformix PLC is listed and trades on the London stock exchange.
Is Nuformix PLC a Good Stock to Buy?
Determining whether Nuformix PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Nuformix PLC share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NFXN quote. (ISIN: GB00BYW79Y38)
London
Currency in GBP
0.2300
-0.0100(-4.17%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.2100
0.2525
52 wk Range
0.0695
0.5550
NFXN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.21000.2525
52 wk Range
0.06950.5550
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
NFXN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Nuformix PLC Company Profile
Nuformix plc, together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. The company develops NXP001, which is in the Phase 1 stage for use in oncology supportive care; NXP002, which is in the pre-clinical stage for the treatment of idiopathic pulmonary fibrosis; and NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology. It has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
Compare NFXN to Peers and Sector
Metrics to compare | NFXN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNFXNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.3x | −4.2x | −0.5x | |
PEG Ratio | 0.00 | 0.02 | 0.00 | |
Price / Book | 6.0x | 2.3x | 2.6x | |
Price / LTM Sales | - | 3.4x | 3.3x | |
Upside (Analyst Target) | - | 69.6% | 45.8% | |
Fair Value Upside | Unlock | −7.1% | 6.4% | Unlock |
Earnings
Latest Release
Dec 03, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Nuformix (NFXN) Stock Price Today?
The Nuformix stock price today is 0.2300
What Stock Exchange Does Nuformix Trade On?
Nuformix is listed and trades on the London Stock Exchange.
What Is the Stock Symbol for Nuformix?
The stock symbol for Nuformix is "NFXN."
What Is the Nuformix Market Cap?
As of today, Nuformix market cap is 4.85M.
What Is Nuformix's Earnings Per Share (TTM)?
The Nuformix EPS (TTM) is -0.00.
When Is the Next Nuformix Earnings Date?
Nuformix will release its next earnings report on Dec 03, 2025.
From a Technical Analysis Perspective, Is NFXN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Nuformix Stock Split?
Nuformix has split 0 times.
How Many Employees Does Nuformix Have?
Nuformix has 3 employees.
What is the current trading status of Nuformix (NFXN)?
As of Feb 08, 2026, Nuformix (NFXN) is trading at a price of 0.2300, with a previous close of 0.2400. The stock has fluctuated within a day range of 0.2100 to 0.2525, while its 52-week range spans from 0.0695 to 0.5550.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.